Close
Smartlab Europe
Inizio Ignite

Drug Research

SK bioscience introduces new partnership model to establish regional vaccine hubs

SK bioscience, a global innovative vaccine and biotech company, introduced a new global partnership model under the title of ‘Preparing for Next Pandemic through Global Partnership’ at the Riyadh Global Medical Biotechnology Summit 2023 (RGBMS 2023) in the Kingdom...

Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, Belgium

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, announced the opening of a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European center of excellence for cell therapies, in Gosselies, Belgium. The...

Zennova Pharmaceuticals Opens Manufacturing and R&D Center in China

Zennova Pharmaceuticals, a Princeton, NJ-based development stage pharmaceutical company focused on complex ophthalmic suspensions and emulsions, hosted a dedication for its manufacturing plant and R&D center on January 11, 2023 in Chengdu, China. The construction of the multi-dosage formulation...

PIK-75 May End Up Being A Saviour Drug For Acute Leukaemia

National University of Singapore researchers have gone ahead and revisited a drug which they believe can be a problem solver when it comes to acute leukaemia. The drug, which is referred to as PIK-75, was initially discovered around 15...

A Biosimilars Pilot Program Is In The Offering By The FDA

The FDA has gone on to release the Biosimilar User Fee Amendments III Regulatory Science Pilot Program, called the Research Roadmap, to give out more information on the biosimilar regulatory science research pilot program. The agency has gone on...

Making Immunotherapy Work In The Tumour Microenvironment

One of the latest studies that takes into account the tumour microenvironment of pancreatic cancer puts forth the cause that tumour cells are resistant to immunotherapy, resulting in new strategies for treatment. The study, which is led by Johns Hopkins...

UK All Set For New Drug Manufacturing Regulatory Framework

As UK will introduce a customised framework for the innovative medicines’ regulation manufactured at the point where the care is received by the patient, it will be the first country to do so, as per the Medicine and Healthcare...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »